Daewoong's Urusa Records Over 36 Billion Won of Sales

Published: 2005-03-11 06:57:00

Updated: 2005-03-11 06:57:00

Daewoong Pharmaceutical recently announced that its popular over-the-counter (OTC) medication Urusa (active ingredient: ursodeoxycholic acid) surpassed over 36 billion won of sales revenue last year, making it as the nation's leading OTC medication in the fatigue relief category.

The company o...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK